These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells. Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580 [TBL] [Abstract][Full Text] [Related]
5. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma. Biserova K; Jakovlevs A; Uljanovs R; Strumfa I Cells; 2021 Mar; 10(3):. PubMed ID: 33799798 [TBL] [Abstract][Full Text] [Related]
7. Targeting glioblastoma stem cells: cell surface markers. He J; Liu Y; Lubman DM Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566 [TBL] [Abstract][Full Text] [Related]
8. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells. Zorniak M; Clark PA; Kuo JS J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488 [TBL] [Abstract][Full Text] [Related]
9. Targeting role of glioma stem cells for glioblastoma multiforme. Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162 [TBL] [Abstract][Full Text] [Related]
10. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy. Pollak J; Rai KG; Funk CC; Arora S; Lee E; Zhu J; Price ND; Paddison PJ; Ramirez JM; Rostomily RC PLoS One; 2017; 12(3):e0172884. PubMed ID: 28264064 [TBL] [Abstract][Full Text] [Related]
11. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy. Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
13. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839 [TBL] [Abstract][Full Text] [Related]
14. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563 [TBL] [Abstract][Full Text] [Related]
15. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521 [TBL] [Abstract][Full Text] [Related]
16. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715 [TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic implications of cancer stem cells in glioblastoma. Cheng L; Bao S; Rich JN Biochem Pharmacol; 2010 Sep; 80(5):654-65. PubMed ID: 20457135 [TBL] [Abstract][Full Text] [Related]
18. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773 [TBL] [Abstract][Full Text] [Related]